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Abstract 
BACKGROUND:  
Few studies have examined epidemiological differences between ethnic groups for 
children and young adults with cancer.   
METHODS:  
Subjects aged 0-29 diagnosed between 1990 and 2005 in the former Yorkshire 
Regional Health Authority were included in the analysis. Ethnicity (south Asian or not) 
was assigned using name analysis programs and Hospital Episode Statistics data. 
Differences in incidence (per 1,000,000 person-years) rates and trends were analysed 
using joinpoint and Poisson regression analysis. 
RESULTS:   
Overall cancer incidence was similar for south Asians (12.1, 95% CI 10.7-13.5; n=275) 
and non-south Asians (12.6, 95% CI 12.2-13.1; n=3259). Annual incidence rates 
increased significantly by 1.9% per year on average (95% CI 1.2-2.6%), especially for 
south Asians (7.0%; 95% CI 4.2-9.9%).  
CONCLUSION:  
If present trends continue, the higher rate of increase seen among the south Asian 
population in Yorkshire will result in 3-times higher incidence than non-south Asians by 
2020. 
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Introduction  
Within Europe and the UK, several cancer epidemiology studies have shown differences 
in incidence rates between ethnic groups across all ages (Jack et al, 2009; Lane et al, 
2007; NCIN, 2009).  
 
Differences in incidence by ethnic group have also been observed amongst children (0-14 
year olds) in the UK. Excesses of all cancers combined, leukaemia, acute myeloid 
leukaemia (AML), lymphoma, germ cell and hepatic tumours has been observed amongst 
south Asians compared to non-south Asians over the last 20 years (Cummins et al, 2001; 
McKinney et al, 2003; Powell et al, 1994; Winter et al, 1999). However, south Asian 
children have displayed lower incidence rates of Wilms’ tumours and rhabdomyosarcoma 
(Powell et al, 1994; Stiller et al, 1991).  Furthermore, the well-described incidence peak for 
leukaemia amongst 2-6 year olds has been observed later in life for south Asians (5-9 
year olds) than for non-south Asians (0-4 year olds) (McKinney et al, 2003; McNally & 
Eden, 2004).  In the US, incidence of leukaemia was higher among Hispanics and lower 
amongst Blacks compared to White children and adolescents (Bleyer, 2002; Matasar et al, 
2006).   
 
While an increasing number of papers have recently reported on the descriptive 
epidemiology of teenage and young adult cancer in the UK, none have focused on 
differences by ethnic group (Birch et al, 2003; Birch et al, 2008). Moreover, it is unclear 
whether incidence differences exist exclusively in the older adult population or whether 
they begin to emerge in adolescence or young adulthood.  
 
The aim of the work was to investigate for the first time in the UK incidence trends by 
ethnic group (south Asian or not) across the childhood (0-14 years) and young adult (15-
29 years) age ranges exploiting the availability of population-based data on paediatric and 
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young adult cancer, whilst utilising information on ethnic group derived and validated 
using a combination of two name analysis programs and linked hospital episode statistics 
(HES) data.    
 
MATERIALS AND METHODS 
Case data 
The data used for this study were extracted from the Yorkshire Specialist Register of 
Cancer in Children and Young People (YSRCCYP), a population-based dataset of 
children (ages 0-14) and young adults (ages 15-29) diagnosed with cancer whilst resident 
in the former Yorkshire Regional Health Authority since 1974 (Feltbower et al, 2009).  
Patients were eligible if diagnosed between 1990 and 2005 aged between 0-29 years.  
Skin carcinomas and melanomas were excluded.  Case details were ascertained from 
hospital clinics and neuropathology departments across the region, and additional 
ascertainment checks undertaken for completeness were carried out with the National 
Registry of Childhood Tumours (www.ccrg.ox.ac.uk) and the Northern and Yorkshire 
Cancer Registry and Information Service (www.nycris.org.uk).  85% of all diagnoses 
recorded on the YSRCCYP have been histologically verified (Feltbower et al, 2009).  
 
Tumour diagnoses were categorised into histological groups according to the International 
Classification of Childhood Cancer (ICCC) (Kramárová et al, 1996). For the purposes of 
certain analyses, malignancies were also grouped into the following four categories to 
retain statistical power: leukaemia, lymphoma, central nervous system (CNS) tumours and 
other solid tumours, corresponding to ICCC codes I, II, III and IV-XII.   
   
The former Yorkshire region contained a population of approximately 1.4 million 0-29 year 
olds at the time of the 2001 census, 8% of whom described are of south Asian ethnic 
origin. This was an increase of 1.5% in the south Asian population since 1991. In 2001, 
 5 
the study area contained 11% of all 0-29 year old south Asians in England, compared to 
only 7.4% of all 0-29 year old non-south Asians.   
 
Assignment of ethnic group 
Historically in the UK cancer registry data on ethnic group has not been routinely, or 
accurately, collected and thus alternative methods have been proposed in order to 
allocate ethnicity. Ethnicity was assigned as either south Asian (i.e. of Pakistani, Indian, or 
Bangladeshi origin) or non-south Asian (all other ethnicities) initially using the south Asian 
names analysis program Nam Pehchan and the South Asian Name and Group 
Recognition Algorithm (SANGRA), with visual inspection by local experts in case of any 
discrepancy. Both programs have a high level of accuracy and Nam Pehchan is 
particularly suited to the south Asian population of Yorkshire (Cummins et al, 1999; 
Nanchahal K et al, 2001).  
 
In addition to both name analysis programs, independent cross-checking was completed 
using ethnicity data available from linked in-patient HES data.  HES records were 
matched via NHS number, date of birth, postcode and sex. 62% (N=2195) of register 
patients were successfully linked to at least one HES record, no ethnic group was 
recorded in HES for 24% (N=517) of the linked patients, thus 1678 (47.5%) of patients’ 
ethnic classification derived from Nam Pehchan and/or SANGRA included in the analysis 
were validated using HES.  For every hospital episode, ethnicity details are collected 
separately which can lead to an individual being allocated multiple ethnicity codes. The 
most frequently recorded ethnicity code was used to overcome this issue if present.  
Ethnicity codes within HES are based on the 16 categories as used in the 2001 census.  
These groups were aggregated to a binary classification of south Asian and non-south 
Asian. In cases where the most common code was listed as ‘unknown’, the most 
commonly occurring known group was used instead.   
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Where clear differences existed between the original 16 category HES code and the 
results of the name analysis (e.g. White British vs. south Asian), HES superseded the 
name analysis classification and the data were changed accordingly.  However, in cases 
where the HES ethnicity code was ambiguous, such as ‘any other Asian’ or ‘any other 
ethnic group’ compared to a name classification of south Asian, the latter ethnicity 
assignment was retained. There was disagreement between assigned ethnicity based on 
HES data and name analysis in just 2.4% (n=40) of cases, of which 23 were re-allocated. 
 
Statistical Analysis 
Incidence rates and trends were examined overall and by major histological subtype. 
Internally age- and sex-standardised incidence rates (per 1,000,000 person years) and 
95% confidence intervals by ethnic group were calculated using mid-year population 
estimates of the former Yorkshire Regional Health Authority based on the 1991 and 2001 
UK census available by single year of age, sex and ethnic group.  Population estimates 
used between 1990 and 2001 incorporated non-responses which were not included in the 
original UK census estimates; these figures also take into account changes in census 
geographies over time (Norman et al, 2008; Sabater & Simpson, 2009). Mid-year 
population estimates between 2002 and 2005 were experimental estimates by ethnic 
group provided by the Office for National Statistics (ONS, 2001 Census).   
 
Incidence rates were calculated by 5-year age band (0-4, 5-9, 10-14, 15-19, 20-24, 25-29 
years), diagnostic group and gender. Incidence trends were assessed by deriving 
smoothed 3-year moving averages for the study period in order to highlight temporal 
patterns within the data.  Initially, joinpoint regression was used to compare differences in 
the incidence of cancer between south Asian and non-south Asian children and young 
people whilst adjusting for sex, age and year of diagnosis.  Poisson regression models 
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were used when joinpoint analysis provided no evidence against a constant average 
annual percentage change (AAPC) in incidence rates.  An interaction term between year 
and ethnic group was included in the best fitting model to assess whether the effect of 
ethnic group changed significantly over time.  Incidence trends by ethnicity were 
forecasted to 2020 by extrapolating predicted values from the final model.  Statistical 
analysis were implemented mostly in Stata 11, joinpoint regression was performed using 
the Joinpoint Regression Program version 3.4.3.  
 
RESULTS 
A total of 3534 children and young adults were registered with a tumour between 1990 
and 2005 whilst living in the former Yorkshire region, of which 275 (7.8%) were south 
Asian.   
 
Incidence  
The number of cases, comparative frequencies and age-sex standardised incidence 
rates by diagnostic group, age group and gender for south and non-south Asians are 
given in Table 1.  The distribution of cases was very similar across ethnic groups, 
except for a higher frequency of 25-29 year old non-south Asian cases compared to 
south Asians. There was a notable excess of male cases compared to females which 
was similar across ethnic groups.  The incidence rate (per 1,000,000 person-years) for 
all cancers in 0-29 year olds between 1990 and 2005 was 12.6 (95% CI 12.2-13.0) 
and was similar overall between ethnic groups. Rates were non-significantly higher for 
south Asians with leukaemia and lymphoma but were lower for central nervous system 
(CNS) and other solid tumours. Slightly higher south Asian rates for all cancers 
combined were observed for those aged 5-9, 10-14 and 15-19, however, this was not 
significant.  There was no significant difference in incidence when comparing male and 
female south Asians and non-south Asians for all tumour groups combined.  
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Age-specific incidence rates by ethnic group for each diagnostic group are given in 
Figure A of the online supplementary material. A small deficit amongst 25-29 year old 
south Asians compared to non-south Asians was seen consistently across all 
diagnostic groups, and was most evident amongst lymphomas and CNS tumours.   
 
Poisson regression models showed that there was a significant difference between the 
incidence rates of south and non-south Asians by diagnostic group (likelihood-ratio 
test for ethnic group and diagnostic group interaction; p=0.01), adjusting for age 
group, sex and year of diagnosis. No significant difference in incidence between age 
group and ethnicity was apparent when testing for an interaction between the two 
variables.  
 
Temporal Trends in Incidence 
Figure 1 displays incidence trends between 1990 and 2005 for all cancers combined 
and each diagnostic group using smoothed 3-year moving averages (MA).  Joinpoint 
regression analysis revealed that the best fitting model for all cancers combined and 
for each diagnostic group was one with no joinpoints, therefore Poisson regression 
was used to calculate the average annual percentage change (AAPC) in each case. 
Overall, there was a significant AAPC of 1.9% (95% CI 1.2-2.6%; p-value < 0.001).  A 
significant change in incidence was also seen for leukaemia (AAPC=1.8%; 95% CI 
0.2-3.4%; p-value = 0.027) and other solid tumours (AAPC=2.9%; 95% CI 1.7-4.1% p-
value < 0.001).  The latter change in incidence was accounted for by rises among 
bone tumours (4.3%; n=151), germ cell neoplasms (4.4%; n=614) and carcinomas 
(5%; n=94). No significant change in incidence was apparent for lymphoma (1.1%) or 
CNS (1.0%) tumours.   
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Likelihood-ratio tests showed significant differences between the temporal change in 
incidence by ethnic group (an interaction between year and ethnicity) for all cancers 
combined (p=0.0002). Joinpoint regression analysis again showed that the best fitting 
model in each case for both south and non-south Asians had no joinpoints, and thus 
the AAPC was calculated using Poisson regression. The rate of increase among south 
Asians was much higher (AAPC=7%; 95% CI 4.2-9.9%) compared to non-south 
Asians (AAPC 1.5%; 95% CI 0.8-2.3%); this finding was even more pronounced for 
those south Asians aged 15-29 (AAPC=11%; 95% CI 4.0-18.0%).  Similarly, there was 
a significantly higher rate of increase for south Asians with lymphoma (AAPC 12.0%, 
95% CI 5%-18%) compared to non-south Asians (AAPC 0.1%; 95% CI -1.5% to 
1.7%), although the number of south Asians with lymphoma between 1990 and 2000 
was extremely small (n=28).  This meant that rates of all cancers combined among 
south Asians matched those of the indigenous population by 2005 despite exhibiting 
much lower rates before the mid-1990s (Figure 1).  This difference in incidence trends 
by ethnic group was not mirrored among those with leukaemia, CNS tumours or other 
solid tumours.     
 
Temporal incidence rates comparing 0-14 year olds and 15-29 year olds by diagnostic 
group showed a significant increase in incidence rates for 15-29 year olds between 
1990 and 2005 for all cancers combined (AAPC=2.9% 95% CI 2.0-3.9%), leukaemia 
(AAPC=4.2%, 95% CI 1.3-7.1%) and other solid tumours (AAPC=4.4%, 95% CI 3.0-
5.9%).  No significant change in incidence was apparent for 0-14 year olds (0.01% for 
all cancers combined).   
 
Figure 2 shows the age- and sex-standardised incidence rates for south and non-
south Asians for all cancers combined alongside predicted incidence rates from 2005 
to 2020.  If the AAPC continues to increase at a constant rate, the incidence of cancer 
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amongst south Asians is set to increase almost 3-fold from 2005 onwards to be 
approximately 56 per million compared to 17 per million for non-south Asians by 2020.   
 
DISCUSSION 
We report details of the first population-based epidemiological study looking at 
incidence rates and trends across the childhood, teenage and young adult age range 
using a validated ethnic group classification.  Previous epidemiological studies 
focusing on ethnic minority populations have relied on a single source of data on 
ethnic group (Cummins et al, 2001; McKinney et al, 2003).  However, our analysis 
incorporated information from the patient’s name alongside a self-reported ethnic 
classification derived from routine hospital admissions.  Although we were able to 
validate only half of the cohort using this data source, mis-classification rates were 
extremely low suggesting that the primary methodology based on name recognition 
software algorithms was an accurate and reliable approach. An estimated 60% of the 
south Asian population within the study region (mainly West Yorkshire) originates from 
Mirpur in rural Pakistan; making it one of the few regions in the UK which allows for a 
detailed analysis of a relatively homogeneous south Asian population (The Change 
Institue & Department for Communities and Local Government, March 2009; Turton & 
Gonzáles, 1999).  We were also able to exploit mid-year population estimates broken 
down by age, sex and crucially ethnic group.  These were derived from recent 
research to enhance previous census and mid-year estimates with adjustments for 
differential non-response by age-sex and ethnic group and upon the most recent ONS 
estimates. We are therefore confident in the accuracy of our population denominator 
and ethnic group assignment. 
 
We found a significantly higher rate of increase in incidence among the south Asian 
population of Yorkshire in comparison to non-south Asians, which resulted in similar 
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overall incidence rates between ethnic groups across the study period (1990-2005).  
This difference in incidence trends was apparent for all cancers combined, but most 
pronounced for lymphoma, and seen in particular among 15-29 year olds.   
 
Our findings suggest there may be an aetiological component, possibly environmental 
in nature, which could be specific to the context of the south Asian population in 
Yorkshire.  Other epidemiological studies focusing on chronic disease epidemiology in 
Yorkshire have suggested there may be a dietary (Edwards et al, 2006) or infectious 
(Feltbower et al, 2005; Parslow et al, 2001) component to aetiology and future work 
should look in more detail especially within the lymphoma group to identify plausible 
causal hypotheses.  The temporal variation in incidence trends by ethnic group could 
in part be confounded by socioeconomic status (Varghese et al, 1996) or genetic 
differences between Mirpuri south Asians and other ethnic groups (De Vos et al, 
2006).  We plan to examine ethnicity with respect to socioeconomic status in a further 
detailed ecological analysis.   
 
The differential increase in incidence among the south Asian population also has 
implications for healthcare resource planners in the region. Our incidence projections 
suggest the burden of disease for south Asians is likely to result in almost 3-times 
higher rates by 2020 assuming that the linear increase since 1990 continues and the 
age structure of the Yorkshire population remains the same over time. The highest 
proportion of south Asians reside within the highly urbanised district of Bradford in 
West Yorkshire, comprising 48% of the total south Asian population of Yorkshire, and 
it is here that the increase in the burden of disease on the NHS will be most strongly 
felt.  
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We saw a slightly higher incidence of leukaemia and lymphoma among south Asians, 
but a deficit for CNS tumours and other solid tumours.  This supports findings from 
previous UK childhood investigations (Cummins et al, 2001; McKinney et al, 2003; 
Powell et al, 1994; Stiller et al, 1991; Winter et al, 1999). Studies which looked at the 
older childhood and young adult age range revealed similar temporal increases in 
incidence which was more pronounced among the other solid tumour groups, 
particularly melanoma and carcinoma (Birch et al, 2002; Kroll et al, 2006; Reedijk et al, 
2005). These changes in incidence could in part be attributed to improvements in 
diagnostic techniques and better case ascertainment more recently, although the latter 
is unlikely due to annual cross-checks with other regional and national cancer 
registries and neuropathology databases since the early 1990s (see methods), whilst 
histological verification of tumours has exceeded 85%. 
 
In summary, despite the similarity in incidence rates between south Asian and non-
south Asians in Yorkshire, our data revealed a sharper increase for the south Asian 
population which if present trends persist will result in a 3-fold higher incidence by 2020 
compared to non-south Asians.   
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Table 1  
Number of cases and age-sex standardised incidence rates for south Asians and non-south Asians by diagnostic group, age group and              
gender (1990-2005) 
 
  
Number of Cases  
  
Incidence Rates 
  South Asian Non-south Asian 
Total  
 
South Asian Non-south Asian 
P-value 
Diagnostic Group Cases (column %) Cases (column %)   Rate (95% CI) Rate (95% CI) 
Leukaemia 66 (24%) 649 (20%) 715 
 
33.6 (25.4-41.7) 30.3 (27.9-32.6) 0.354 
Lymphoma 71 (26%) 689 (21%) 760 
 
37.8 (28.9-46.6) 31.9 (29.5-34.3) 0.074 
CNS Tumours 37 (13%) 562 (17%) 599 
 
19.4 (13.1-25.7) 26.1 (24.0-2.83) 0.111 
Other Solid Tumours 101 (37%) 1359 (42%) 1,460 
 
6.1 (4.9-7.3) 7.0 (6.6-7.4) 0.191 
        Age at diagnosis (years) 
       0-4 66 (24%) 650 (20%) 716 
 
16.2 (12.3-20.1) 16.1 (14.8-17.3) 0.918 
5-9 40 (15%) 364 (11%) 404 
 
10.5 (7.2-13.8) 8.5 (7.7-9.4) 0.225 
10-14 37 (13%) 375 (12%) 412 
 
10.5 (7.1-13.9) 8.7 (7.9-9.6) 0.28 
15-19 42 (15%) 463 (14%) 505 
 
11.3 (7.9-14.7) 10.9 (9.9-11.9) 0.723 
20-24 41 (15%) 597 (18%) 638 
 
10.4 (7.2-13.6) 13.4 (12.3-14.5) 0.181 
25-29 49 (18%) 810 (25%) 859 
 
14.2 (10.2-18.2) 18.1 (16.8-19.3) 0.146 
        Gender 
       Male 159 (58%) 1995 (61%) 2,154 
 
14.2 (12.0-16.4) 15.3 (14.6-15.9) 0.555 
Female 116 (42%) 1264 (39%) 1,380 
 
10.0 (8.2-11.8) 9.9 (9.4-10.5) 0.744 
        Total  275 3,259 3,534  12.1 (10.7-13.5) 12.6 (12.2-13.1) 0.801 
 
 
 
